PEP07
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PEP07, covering 2024-11-07 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer [Phase 1]